|
1
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner AD, Arnold D, Grothey AA, Haerting
J and Unverzagt S: Anti-angiogenic therapies for metastatic
colorectal cancer. Cochrane Database Syst Rev.
8:CD0053922009.PubMed/NCBI
|
|
4
|
Hua Z, Lv Q, Ye W, et al: MiRNA-directed
regulation of VEGF and other angiogenic factors under hypoxia. Plos
One. 1:E1162006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuehbacher A, Urbich C, Zeiher AM and
Dimmeler S: Role of Dicer and Drosha for endothelial microRNA
expression and angiogenesis. Circ Res. 101:59–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
miR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo C, Sah JF, Beard L, Willson JK,
Markowitz SD and Guda K: The noncoding RNA, miR-126, suppresses the
growth of neoplastic cells by targeting phosphatidylinositol
3-kinase signaling and is frequently lost in colon cancers. Genes
Chromosomes Cancer. 47:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nicoli S, Standley C, Walker P, Hurlstone
A, Fogarty KE and Lawson ND: MicroRNA-mediated integration of
haemodynamics and Vegf signalling during angiogenesis. Nature.
464:1196–1200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang S, Aurora AB, Johnson BA, Qi X,
McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ: Oncomirs
– microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269.
2006.
|
|
11
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Faber C, Kirchner T and Hlubek F: The
impact of microRNAs on colorectal cancer. Virchows Arch.
454:359–367. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
14
|
Yamamichi N, Shimomura R, Inada K, et al:
Locked nucleic acid in situ hybridization analysis of miR-21
expression during colorectal cancer development. Clin Cancer Res.
15:4009–4016. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Díaz R, Silva J, Garcia JM, Lorenzo Y,
Garcia V, Pena C, Rodriguez R, Munoz C, Garcia F, Bonilla F and
Dominguez G: Deregulated expression of miR-106a predicts survival
in human colon cancer patients. Genes Chromosomes Cancer.
47:794–802. 2008.PubMed/NCBI
|
|
16
|
Schepeler T, Reinert JT, Ostenfeld MS, et
al: Diagnostic and prognostic microRNAs in stage II colon cancer.
Cancer Res. 68:6416–6424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu
CG, Calin GA, Croce CM and Harris CC: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. Jama. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hansen TF, Spindler KL, Lorentzen KA,
Olsen DA, Andersen RF, Lindebjerg J, Brandslund I and Jakobsen A:
Quantitative analysis of vascular endothelial growth factor
receptors 1 and 2 in colorectal cancer. Mol Med Reports. 2:787–792.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hansen TF, Sorensen FB, Spindler KL, Olsen
DA, Andersen RF, Lindebjerg J, Brandslund I and Jakobsen A:
Microvessel density and the association with single nucleotide
polymorphisms of the vascular endothelial growth factor receptor 2
in patients with colorectal cancer. Virchows Arch. 456:251–260.
2010. View Article : Google Scholar
|
|
20
|
Andersen CL, Jensen JL and Orntoft TF:
Normalization of real-time quantitative reverse transcription-PCR
data: a model-based variance estimation approach to identify genes
suited for normalization, applied to bladder and colon cancer data
sets. Cancer Res. 64:5245–5250. 2004. View Article : Google Scholar
|
|
21
|
Jorgensen S, Baker A, Moller S and Nielsen
BS: Robust one-day in situ hybridization protocol for
detection of microRNAs in paraffin samples using LNA probes.
Methods. 52:375–381. 2010.
|
|
22
|
Kuhnert F, Mancuso MR, Hampton J,
Stankunas K, Asano T, Chen CZ and Kuo CJ: Attribution of vascular
phenotypes of the murine Egfl7 locus to the microRNA miR-126.
Development. 135:3989–3993. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ionov Y, Peinado MA, Malkhosyan S, Shibata
D and Perucho M: Ubiquitous somatic mutations in simple repeated
sequences reveal a new mechanism for colonic carcinogenesis.
Nature. 363:558–561. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Des GG, Uzzan B, Nicolas P, Cucherat M,
Morere JF, Benamouzig R, Breau JL and Perret GY: Microvessel
density and VEGF expression are prognostic factors in colorectal
cancer. Meta-analysis of the literature. Br J Cancer. 94:1823–1832.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuehbacher A, Urbich C and Dimmeler S:
Targeting microRNA expression to regulate angiogenesis. Trends
Pharmacol Sci. 29:12–15. 2008. View Article : Google Scholar
|
